Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers
NCT03033095
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Spondylitis, Ankylosing
Interventions
DRUG:
Etanercept ® 50 mg
Sponsor
University Hospital, Grenoble